GleanMark

STAGEOSIS Trademark

STAGEOSIS is a USPTO trademark filed by GENFIT. Status: Registered.

Trademark Facts

MarkSTAGEOSIS
Serial Number79408532
Registration Number7877216
StatusRegistered
Filing Date2024-09-19
Registration Date2025-08-05
Mark TypeWord
Nice Classes001 (Chemicals), 005 (Pharmaceuticals), 009 (Electronics & Software), 010 (Medical Devices), 042 (Software & IT), 044 (Medical Services)
OwnerGENFIT
Attorney of RecordRonald M. Kachmarik
Prosecution Events26
Latest EventOPNX on 2026-04-16

Goods & Services

Downloadable and recorded software for use in the management of cancer, metabolic diseases and liver diseases, namely, software for creating customized care plans for patients, for managing patient data, for providing clinical decision support information and analytics, for managing patient medications, and for providing reporting and analytics relating to patient care, and for use in research and development of new pharmaceutical products for others, namely, software for managing, analyzing and reporting on clinical trial data; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments for recording, processing, reproduction and transmission of data, namely electronic data loggers and recorders; data processing equipment; Pharmaceutical preparations for the diagnosis, prevention and treatment of metabolic, hepatic and oncological diseases and disorders; diagnostic preparations and diagnostic biomarker reagents for medical use; medical diagnostic testing materials for medical use namely, diagnostic reagents and assays for testing of bodily fluids; blood and blood-derived samples for medical use, namely, blood substitutes for human use, blood plasma, serum and other blood-derived biological samples; Diagnostic preparations for industrial and scientific use; chemical reagents for industrial use; chemical reagents for scientific use; Medical analysis for the diagnosis, prevention and treatment of metabolic, hepatic and oncological diseases and disorders; medical analysis of blood samples; assistance services in the fields of medicine and health care; medical information; provision of medical information; Medical apparatus, instruments and equipment namely, DNA, RNA and protein analysis apparatus, DNA, RNA and protein quantifiers, medical devices for measuring DNA, RNA, biochemical and physical parameters, namely, concentration of biomarkers and blood analyzers for evaluation of metabolic, hepatic and oncological diseases and disorders; instruments and tools for medical diagnosis, namely diagnostic medical devices for diagnosis of metabolic, hepatic and oncological diseases and disorders, blood analysis apparatus, DNA and RNA analysis apparatus, gene analyzers, medical devices for measuring biochemical and physical parameters, namely, concentration of biomarkers relating to the evaluation of metabolic, hepatic and oncological diseases and disorders, and blood analyzers for evaluation of metabolic, hepatic and oncological diseases and disorders; Scientific and technological services, namely research in the medical, biomedical, and chemical fields, for the diagnosis, prevention and treatment of metabolic, hepatic and oncological diseases and disorders; biological research; clinical research and medical research in the field of diagnosis, prevention and treatment of metabolic, hepatic and oncological diseases and disorders; industrial analysis and industrial research services in the field of pharmacy; design and development of computer hardware and software; programming for computers

Related